AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.100
+0.040 (1.94%)
At close: May 13, 2025, 4:00 PM
2.080
-0.020 (-0.95%)
Pre-market: May 14, 2025, 7:05 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $625.77 million as of May 14, 2025. Its market cap has decreased by -41.12% in one year.
Market Cap
625.77M
Enterprise Value
83.72M
1-Year Change
-41.12%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $625.77M, a decrease of -96.01%. That is a compound annual growth rate of -51.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 613.85M | -29.07% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.43B |
| Johnson & Johnson | 370.23B |
| UnitedHealth Group | 347.14B |
| AbbVie | 333.92B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.15B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |